(Q42519219)

1 November 2017

Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells (English)

1 reference

1 November 2017

0 references

Saioa Gomez-Zorita

1

1 reference

1 November 2017

Karine Tréguer

series ordinal

2

1 reference

1 November 2017

Josep Mercader

series ordinal

3

1 reference

1 November 2017

Christian Carpéné

series ordinal

4

1 reference

1 November 2017

13 January 2013

1 reference

Journal of Physiology and Biochemistry

1 November 2017

1 reference

1 November 2017

69

1 reference

1 November 2017

3

1 reference

1 November 2017

585-593

1 reference

https://scigraph.springernature.com/pub.10.1007/s13105-012-0229-0

1 November 2017

0 references

cites work

Resveratrol alleviates alcoholic fatty liver in mice

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Amine oxidase-like activity of polyphenols. Mechanism and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Changes in white adipose tissue metabolism induced by resveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

High lipolytic activity and dyslipidemia in a spontaneous hypertensive/NIH corpulent (SHR/N-cp) rat: a genetic model of obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Possible mechanisms of weight loss of Siberian hamsters (Phodopus sungorus sungorus) exposed to short photoperiod

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Effect of resveratrol on fat mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARγ1-3 mRNA expression in human visceral adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Reactive oxygen species facilitate translocation of hormone sensitive lipase to the lipid droplet during lipolysis in human differentiated adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol regulates lipolysis via adipose triglyceride lipase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol enhances fatty acid oxidation capacity and reduces resistin and Retinol-Binding Protein 4 expression in white adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Dietary antioxidants interfere with Amplex Red-coupled-fluorescence assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Anti-diabetic effects of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-012-0229-0

Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium

21 January 2018

1 reference

12 December 2020

Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice

1 reference

12 December 2020

Resveratrol and genistein as adenosine triphosphate-depleting agents in fat cells

1 reference

12 December 2020

Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter

1 reference

12 December 2020

The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity

1 reference

12 December 2020

10.1007/S13105-012-0229-0

Identifiers

DOI

1 reference

1 November 2017

1 reference